MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up
The Bayesian analysis provides a useful harm reduction endpoint interpretation of drinking in terms of a 2-level reduction in WHO drinking risk. Further findings provide preliminary insights into the potential impact of MDMA-assisted psychotherapy on quality of life and well-being in addition to reductions in drinking. ClinicalTrials.gov ID: NCT04158778.
Authors
- Claire Durant
- Laurie Higbed
- Celia J. A. Morgan (ORCID: https://orcid.org/0000-0002-8858-4906)
- Hannah Thurgur (ORCID: https://orcid.org/0000-0001-7714-3446)
- Ben Sessa (ORCID: https://orcid.org/0000-0002-1212-6060)
- Steve O’Brien (ORCID: https://orcid.org/0000-0002-9567-9997)
- Balázs Szigeti (ORCID: https://orcid.org/0000-0003-3809-6442)
- David Nutt (ORCID: https://orcid.org/0000-0002-6423-9411)
- Sue Wilson
Institutions
- University of California, San Francisco (US)
- University of Exeter (GB)
- Imperial College London (GB)
Publication Details
- Journal
- Alcohol and Alcoholism
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1093/alcalc/agaf031
- Citations
- 2
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 2.79